Table 1 The percentages of cell viability of PC-3 after 48 h co‐culture system with activated PBMCs at 24 and 48 h with treatments at the concentration of 50 µg/mL.

From: Barleria extracts containing barlerin and verbascoside boost immunity and regulate CYP450 gene in prostate cancer

Condition

24 h activated PBMCs

48 h activated PBMCs

% cell viability

% cell viability

Co-culture period

24 h

48 h

24 h

48 h

Media + DMSO

100.00 ± 0.00a

100.00 ± 0.00a

100.00 ± 0.00a

100.00 ± 0.00a

PBMCs + DMSO

94.74 ± 1.27a

95.60 ± 1.59a

102.43 ± 5.50a

98.03 ± 2.95a

Media + B. cristata

97.78 ± 2.45a

98.13 ± 4.28a

99.21 ± 2.62a

96.42 ± 1.86a

PBMCs + B. cristata

97.47 ± 2.62a

96.75 ± 2.53a

107.03 ± 5.97a

41.25 ± 2.35b

Media + B. siamensis

97.07 ± 2.93a

95.45 ± 4.80a

104.50 ± 4.42a

95.60 ± 2.27a

PBMCs + B. siamensis

98.44 ± 1.51a

97.50 ± 6.74a

61.30 ± 3.02b

30.96 ± 4.06b

Media + B. strigosa

99.14 ± 2.00a

97.39 ± 1.19a

103.97 ± 7.12a

96.24 ± 2.75a

PBMCs + B. strigosa

100.95 ± 2.48a

94.10 ± 1.62a

107.12 ± 3.53a

72.69 ± 7.53b

Media + Barlein

96.82 ± 1.81a

95.48 ± 5.01a

99.19 ± 5.49a

99.62 ± 5.68a

PBMCs + Barlerin

94.09 ± 3.13a

93.37 ± 1.46a

99.55 ± 8.71a

71.16 ± 3.03b

Media + Verbascoside

92.84 ± 1.04a

91.22 ± 1.36a

104.39 ± 3.25a

96.92 ± 1.87a

PBMCs + Verbascoside

93.98 ± 4.63a

88.53 ± 6.20a

100.63 ± 6.97a

62.37 ± 0.95b

Blank system

Media (Blank)-no PC-3

0.06 ± 0.001a

0.06 ± 0.003a

0.06 ± 0.011a

0.06 ± 0.002a

Media + PBMCs + DMSO-no PC‐3

0.06 ± 0.005a

0.05 ± 0.003a

0.07 ± 0.014a

0.05 ± 0.002a

  1. The data was normalized to the percentage of PC‐3 cell viability treated with culture media containing DMSO.
  2. All data was represented in mean ± S.D. a = p-value > 0.05, b = p‐value < 0.0001, which is compared to DMSO as a control.